AstraZeneca · 1 day ago
Director, Clinical Pharmacology & Quantitative Pharmacology (CPQP)- Oncology
AstraZeneca is a leading company in the field of oncology, seeking a Director of Clinical Pharmacology & Quantitative Pharmacology to lead model-informed drug development. The role involves setting clinical pharmacology strategy, integrating advanced modeling with biomarkers, and mentoring teams to enhance decision-making in drug development.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Build and embed a culture encouraging of MIDD in oncology; influence partners, stakeholders, and regulators on its value and application to elevate decision quality and speed
Plan and complete groundbreaking clinical pharmacology approaches with direct value across the portfolio, enabling clear decision points and optimized development paths
Provide scientific and strategic feedback into pre-clinical, clinical, and post-approval plans to ensure coherent, data-driven strategies that reduce uncertainty
Guide the supervision, support, and application of clinical pharmacology strategies in oncology through both early and late phases, managing dose selection, exposure–response analysis, and risk management
Support assessment of candidates for in- and out-licensing, using quantitative evidence to assess opportunity, risk, and strategic fit
Contribute to drug–disease models and other modeling approaches to support internal and external decision making, collaborating with internal teams and external partners when relevant
Partner with the Oncology and discipline lead on strategy, scientific operations, and business management to align priorities and resources
Provide peer review and mentoring within and across therapeutic areas, strengthening scientific difficulty and consistency
Deliver training and knowledge sharing to advance the Clinical Pharmacology discipline and scale best practices
Supervise internal and external environments for relevant new methodologies and applications to keep approaches current and competitive
Increase AstraZeneca’s external profile in clinical pharmacology/MIDD through speaking engagements and publications in recognized journals to build industry thinking
Ensure clinical pharmacology strategies align with current regulatory expectations, supporting successful submissions and interactions
Qualification
Required
Leadership in developing and embedding a culture supportive of MIDD in oncology, with influence across partners, stakeholders, and regulators
Ability to plan and implement state-of-the-art clinical pharmacology approaches that drive portfolio value and enable go/no-go decision making
Evidence-based and forward-thinking input spanning pre-clinical, clinical, and post-approval development
Supervision, guidance, and delivery of oncology clinical pharmacology plans across early and late development
Experience supporting evaluation of candidates for in- and out-licensing
Contribution to drug–disease models alongside other modeling techniques for decision support, in collaboration with internal and external partners
Support for discipline leadership in strategy, scientific operations, and business management
Proven peer review and mentoring across therapeutic areas
Dedication to providing education and sharing expertise to develop the Clinical Pharmacology field
Active monitoring of emerging techniques and implementations relevant to clinical pharmacology and MIDD
Established external presence through speaking engagements and publications
Ensuring alignment of clinical pharmacology plans with current regulatory expectations
Preferred
Experience integrating quantitative pharmacology alongside innovative biological indicators, AI-enabled analyses, innovative endpoints, and modern trial builds
Track record of leading cross-functional, global teams to deliver sophisticated clinical pharmacology strategies at pace
Familiarity with emerging and non-traditional drug modalities and their clinical pharmacology considerations
Strong record of impactful publications and scientific presentations that influence practice or policy
Ability to translate sophisticated modeling outputs into clear, actionable insights for diverse stakeholders, including senior leaders and regulators
Experience collaborating with external consortia, academic partners, or industry groups to advance MIDD methodologies
Benefits
Short-term incentive bonuses
Equity-based awards for salaried roles
Commissions for sales roles
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
H1B Sponsorship
AstraZeneca has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (2)
2020 (11)
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Recent News
2026-01-09
2026-01-09
2026-01-09
Company data provided by crunchbase